comparemela.com

Latest Breaking News On - Avistone pharmaceuticals - Page 1 : comparemela.com

The top five private biotech companies in China

China has a thriving biotech venture capital scene, with firms bagging impressive cash in the last few years. Check out our pick of five private healthcare biotech companies that have raised major rounds in China.

Fierce Pharma Asia—China s new NRDL; Biocon-Viatris biosimilar merger?; Avistone s $200M series A

Big Pharma's cancer immunotherapies were once again excluded from China's national reimbursement. Biocon and Viatris are reportedly considering combining their biosimilar operations. A Chinese oncology biotech just secured a handsome $200 million series A. And more.

vimarsana © 2020. All Rights Reserved.